TrialMolecular therapy : the journal of the American Society of Gene Therapy2021

Iduronate-2-sulfatase fused with anti-hTfR antibody, pabinafusp alfa, for MPS-II: A phase 2 trial in Brazil.

Roberto Giugliani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.